Literature DB >> 21463229

Hypoparathyroidism in pregnancy.

Robert Krysiak1, Iwona Kobielusz-Gembala, Bogusław Okopien.   

Abstract

Pregnancy and lactation are associated with remarkable changes in calcium homeostasis, resulting from pregnancy-induced alterations in the production, metabolism and excretion of calcium and calcitropic hormones. Therefore, the clinical course of disorders affecting the parathyroid glands during pregnancy and lactation is often atypical. As the symptoms experienced by patients with parathyroid disorders are not specific, their diagnosis during gestation and breastfeeding may be sometimes very difficult. If left untreated, parathyroid disorders may pose a significant risk to the mother and fetus associated with increased perinatal and maternal morbidity and mortality. Hypoparathyroidism is a disorder rarely observed during pregnancy, resulting in most cases from surgical thyroidectomy. In our article, we present the case of a 32-year-old female with primary hypoparathyroidism diagnosed for the first time during pregnancy. We describe in details the treatment strategies undertaken in this patient and their impact on the outcome of pregnancy and lactation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463229     DOI: 10.3109/09513590.2010.507284

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

Review 1.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

2.  Management of hypoparathyroidism in pregnancy and lactation - A report of 10 cases.

Authors:  B L Hatswell; C A Allan; J Teng; P Wong; P R Ebeling; E M Wallace; P J Fuller; F Milat
Journal:  Bone Rep       Date:  2015-06-30

Review 3.  Hypoparathyroidism in Pregnancy and Lactation: Current Approach to Diagnosis and Management.

Authors:  Dalal S Ali; Karel Dandurand; Aliya A Khan
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.